AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A Joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study
Authors: Adamson, PC Widemann, BC Reaman, GH Seibel, NL Murphy, RF Gillespie, AF Balis, FM
Citation: Pc. Adamson et al., A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A Joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study, CLIN CANC R, 7(10), 2001, pp. 3034-3039
A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities
Authors: Bracho, F Krailo, MD Shen, V Bergeron, S Davenport, V Liu-Mares, W Blazar, BR Panoskaltsis-Mortari, A van de Ven, C Secola, R Ames, MM Reid, JM Reaman, GH Cairo, MS
Citation: F. Bracho et al., A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities, CLIN CANC R, 7(1), 2001, pp. 58-67
Prognostic factors and secondary malignancies in childhood medulloblastoma
Authors: Stavrou, T Bromley, CM Nicholson, HS Byrne, J Packer, RJ Goldstein, AM Reaman, GH
Citation: T. Stavrou et al., Prognostic factors and secondary malignancies in childhood medulloblastoma, J PED H ONC, 23(7), 2001, pp. 431-436
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report
Authors: Cairo, MS Shen, V Krailo, MD Bauer, M Miser, JS Sato, JK Blatt, J Blazar, BR Frierdich, S Liu-Mares, W Reaman, GH
Citation: Ms. Cairo et al., Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report, J PED H ONC, 23(1), 2001, pp. 30-38
Pet ownership and childhood acute leukemia (USA and canada)
Authors: Swensen, AR Ross, JA Shu, XO Reaman, GH Steinbuch, M Robison, LL
Citation: Ar. Swensen et al., Pet ownership and childhood acute leukemia (USA and canada), CANC CAUSE, 12(4), 2001, pp. 301-303
Developmental therapeutics in childhood cancer - A perspective from the Children's Oncology Group and the US Food and Drug Administration
Authors: Bernstein, ML Reaman, GH Hirschfeld, S
Citation: Ml. Bernstein et al., Developmental therapeutics in childhood cancer - A perspective from the Children's Oncology Group and the US Food and Drug Administration, HEMAT ONCOL, 15(4), 2001, pp. 631
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma
Authors: Pui, CH Mahmoud, HH Wiley, JM Woods, GM Leverger, G Camitta, B Hastings, C Blaney, SM Relling, MV Reaman, GH
Citation: Ch. Pui et al., Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma, J CL ONCOL, 19(3), 2001, pp. 697-704
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguaninein children with acute lymphoblastic leukemia: a collaborative pediatric oncology branch, NCI, and Children's Cancer Group study
Authors: Lowe, ES Kitchen, BJ Erdmann, G Stork, LC Bostrom, BC Hutchinson, R Holcenberg, J Reaman, GH Woods, W Franklin, J Widemann, BC Balis, FM Murphy, RF Adamson, PC
Citation: Es. Lowe et al., Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguaninein children with acute lymphoblastic leukemia: a collaborative pediatric oncology branch, NCI, and Children's Cancer Group study, CANC CHEMOT, 47(3), 2001, pp. 199-205
Phase I study of CI-958 in children and adolescents with recurrent solid tumors
Authors: Arndt, CAS Krailo, MD Wen, LM Anderson, PM Reaman, GH
Citation: Cas. Arndt et al., Phase I study of CI-958 in children and adolescents with recurrent solid tumors, CANCER, 91(6), 2001, pp. 1166-1169
INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction
Authors: Carter, TL Reaman, GH Kees, UR
Citation: Tl. Carter et al., INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction, BR J HAEM, 113(2), 2001, pp. 323-328
Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse
Authors: Carter, TL Watt, PM Kumar, R Burton, PR Reaman, GH Sather, HN Baker, DL Kees, UR
Citation: Tl. Carter et al., Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse, BLOOD, 97(2), 2001, pp. 572-574
Response: p16(INK4A) gene deletion in pediatric acute lymphoblastic leukemia
Authors: Kees, UR Carter, TL Watt, PM Kumar, R Baker, DL Reaman, GH Sather, HN Burton, PR
Citation: Ur. Kees et al., Response: p16(INK4A) gene deletion in pediatric acute lymphoblastic leukemia, BLOOD, 97(12), 2001, pp. 4003-4004
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia
Authors: Uckun, FM Stork, L Seibel, N Sarquis, M Bedros, C Sather, H Sensel, M Reaman, GH Gaynon, PS
Citation: Fm. Uckun et al., Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia, CLIN CANC R, 6(8), 2000, pp. 3123-3130
The nuclear migration gene NudC and human hematopoiesis
Authors: Gocke, CD Reaman, GH Stine, C Zhang, MY Osmani, SA Miller, BA
Citation: Cd. Gocke et al., The nuclear migration gene NudC and human hematopoiesis, LEUK LYMPH, 39(5-6), 2000, pp. 447
Prognostic impact of trisomies of chromosomes 10, 17, and 5 among childrenwith acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)
Authors: Heerema, NA Sather, HN Sensel, MG Zhang, T Hutchinson, RJ Nachman, JB Lange, BJ Steinherz, PG Bostrom, BC Reaman, GH Gaynon, PS Uckun, FM
Citation: Na. Heerema et al., Prognostic impact of trisomies of chromosomes 10, 17, and 5 among childrenwith acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes), J CL ONCOL, 18(9), 2000, pp. 1876-1887
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: A Children's Cancer Group Study
Authors: Ozkaynak, MF Sondel, PM Krailo, MD Gan, J Javorsky, B Reisfeld, RA Matthay, KK Reaman, GH Seeger, RC
Citation: Mf. Ozkaynak et al., Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: A Children's Cancer Group Study, J CL ONCOL, 18(24), 2000, pp. 4077-4085
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia
Authors: Heerema, NA Sather, HN Sensel, MG Lee, MK Hutchinson, RJ Nachman, JB Reaman, GH Lange, BJ Steinherz, PG Bostrom, BC Gaynon, PS Uckun, FM
Citation: Na. Heerema et al., Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia, J CL ONCOL, 18(22), 2000, pp. 3837-3844
Intracranial calcifications in childhood medulloblastoma: Relation to nevoid basal cell carcinoma syndrome
Authors: Stavrou, T Dubovsky, EC Reaman, GH Goldstein, AM Vezina, G
Citation: T. Stavrou et al., Intracranial calcifications in childhood medulloblastoma: Relation to nevoid basal cell carcinoma syndrome, AM J NEUROR, 21(4), 2000, pp. 790-794
Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis
Authors: Savage, SA Young, C Reaman, GH
Citation: Sa. Savage et al., Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis, MED PED ONC, 34(3), 2000, pp. 215-217
Paternal military service and risk for childhood leukemia in offspring
Authors: Wen, WQ Shu, XO Steinbuch, M Severson, RK Reaman, GH Buckley, JD Robison, LL
Citation: Wq. Wen et al., Paternal military service and risk for childhood leukemia in offspring, AM J EPIDEM, 151(3), 2000, pp. 231-240
Breast-feeding and risk of childhood acute leukemia
Authors: Shu, XO Linet, MS Steinbuch, M Wen, WQ Buckley, JD Neglia, JP Potter, JD Reaman, GH Robison, LL
Citation: Xo. Shu et al., Breast-feeding and risk of childhood acute leukemia, J NAT CANC, 91(20), 1999, pp. 1765-1772
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia
Authors: Sun, L Crotty, ML Sensel, M Sather, H Navara, C Nachman, J Steinherz, PG Gaynon, PS Seibel, N Mao, C Vassilev, A Reaman, GH Uckun, FM
Citation: L. Sun et al., Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia, CLIN CANC R, 5(8), 1999, pp. 2112-2120
Evaluation of temozolomide in a SCID mouse model of human B-cell precursorleukemia
Authors: Messinger, Y Reaman, GH Ek, O Uckun, FM
Citation: Y. Messinger et al., Evaluation of temozolomide in a SCID mouse model of human B-cell precursorleukemia, LEUK LYMPH, 33(3-4), 1999, pp. 289-293
Poor treatment outcome of Philadelphia chromosome-positive pediatric acutelymphoblastic leukemia despite intensive chemotherapy
Authors: Uckun, FM Nachman, JB Sather, HN Sensel, MG Kraft, P Steinherz, PG Lange, B Hutchinson, R Reaman, GH Gaynon, PS Heerema, NA
Citation: Fm. Uckun et al., Poor treatment outcome of Philadelphia chromosome-positive pediatric acutelymphoblastic leukemia despite intensive chemotherapy, LEUK LYMPH, 33(1-2), 1999, pp. 101-106
Prognostic significance of T-lineage leukemic cell growth in SCID mice: A children's cancer group study
Authors: Uckun, FM Waurzyniak, BJ Sather, HN Sensel, MG Chelstrom, L Nachman, J Gaynon, PS Bostrom, B Ek, O Sarquis, M Steinherz, PG Reaman, GH
Citation: Fm. Uckun et al., Prognostic significance of T-lineage leukemic cell growth in SCID mice: A children's cancer group study, LEUK LYMPH, 32(5-6), 1999, pp. 475
Risultati: 1-25 | 26-31